The Economic Times, US Story by Maitreyee Thakkar, Global Desk For decades, advances in battlefield medicine have focused on one goal: keep the wounded alive long enough to reach a surgical facility. Tourniquets, hemostatic dressings, rapid evacuation, and forward surgical teams dramatically improved survival in Iraq and Afghanistan. Yet one…
Read More
THE WOODLANDS, Texas and HUMMELSTOWN, Pa., March 17, 2026 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced a strategic collaboration with BobcatBio, a clinical-stage biotechnology company that is pioneering the development of RB-1355, a first of its kind cellular therapy that leverages the versatility and…
Read More
Becomes go-to AI intelligence layer and clinical decision support tool across 100+ hospitals NEWARK, N.J., Feb. 19, 2026 /PRNewswire/ -- Wellsheet, a leader in AI clinical workflows and operations, was recently named one of 2025's most promising startups. Wellsheet is gaining traction as hospitals grapple with clinician burnout and data overload. Its technology is live…
Read More
Healthcare is transforming rapidly, driven by technological advancements, evolving patient expectations and shifting demographics. While these changes propel our industry forward, significant gaps in access continue. As we enter this new era, it is critical that we partner with clinicians across the industry to constantly explore new ways to optimize.…
Read More
Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed funding of USD 6 million Allschwil, Switzerland, September 25, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections,…
Read More
Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic Allschwil, Switzerland, August 14, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered into an exclusive license agreement…
Read More
Wellsheet launches multidisciplinary AI Copilot to reduce charting time by 50% AI improves chart summarization, multidisciplinary rounding coordination and streamlines discharge planning and documentation NEW YORK, July 17, 2025 /PRNewswire/ -- Wellsheet, a leader in AI clinical workflows and operations, today announced a new Care Team Copilot that combines chart summarization, multidisciplinary rounding and…
Read More
Bainbridge Health Welcomes B. Braun to the National Infusion Collaborative™ Bainbridge Health announced that B. Braun Medical Inc. (B. Braun) has joined the National Infusion Collaborative (NIC) PHILADELPHIA, PA, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- Bainbridge Health, a leading provider of medication safety and stewardship solutions, today announced that…
Read More
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio MILFORD, Mass., May 21, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene…
Read More
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™ Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programs DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced its…
Read More